The effects of aztreonam on fecal flora and on descarboxy prothrombin (PIVKA-H) in plasma and -y-carboxyglutamic acid (Gla) in urine as an index of vitamin K metabolism were studied in seven children (age range, 2 months to 2 years) with urinary tract infections. Daily doses of aztreonam were 60 to 80 mg/kg. Stool specimens were obtained before the treatment, on days 3 to 5 of aztreonam use, and from 3 to 5 days after the cessation of treatment. The counts of enterobacteria decreased (P < 0.01) and those of streptococci increased (P < 0.05) during aztreonam treatment. The anaerobic organisms, especially bifidobacteria and bacteroides, showed no marked change. PIVKA-IH and Gla were investigated before and during the treatment with aztreonam. PIVKA-II was not detected in seven patients before or during aztreonam use. There were no significant differences in the levels of Gla in urine before or during the treatment.Aztreonam is a monobactam antibiotic which has high activity against many aerobic gram-negative bacilli, but it has low activity against gram-positive cocci and anaerobic bacteria (4, 9). The clinical efficacy of aztreonam in aerobic gram-negative infections has been shown by many investigators (7,24). The impact of antibiotics on fecal flora is well-known, and the effects of some antibiotics on fecal flora have been reported (5,22,25). Although aztreonam might be expected to have little influence on fecal flora because of the features of activity of this agent against bacteria, there are few reports about the effect of aztreonam on fecal flora (6).The hypoprothrombinemia caused by vitamin K deficiency is also one of the important adverse effects induced by antibiotics, especially the broad-spectrum cephalosporins which have the N-methylthiotetrazole side chain, such as moxalactam, cefoperazone, and cefmetazole (12,18,20,21). In this study, we set out to evaluate the effects of aztreonam on fecal flora. We also measured descarboxy prothrombin (PIVKA-II) in plasma and y-carboxyglutamic acid (Gla) in urine in order to discover the effect of this antibiotic on vitamin K metabolism.
MATERIALS AND METHODSSeven children (age range, 2 months to 2 years) hospitalized in the Asahikawa Medical College Hospital for the treatment of urinary tract infections were used as subjects for this study. No antibiotics were administered before the study. They received aztreonam intravenously in a 20-mg/kg dose every 6 or 8 h during 3 to 14 days.Stool specimens were obtained before treatment, from days 3 to 5 of antibiotic use, and from 3 to 5 days after the cessation of drug administration. Plasma and urine were taken from patients before treatment and from days 3 to 5 of antibiotic use. Quantitative aerobic and anaerobic cultures were undertaken by a method described previously (22). Stool specimens were immediately put into a sterile transport medium filled with CO2 gas and stored at 4°C until they were cultured. The specimens were homogenized and serially diluted 10-fold in a buffer solution which was prereduced under an...